Diagnosis: Contemporary medical hubris; Rx: A tincture of humility

Journal of Evaluation in Clinical Practice

Volumn 12, Issue 1, 2006, Pages 24-30

  Genuis, Stephen J ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NONE   (Canada)

Author keywords

Evidence based medicine; Iatrogenic illness; Medical education; Medical professionalism; Medical research; Pharmaceutical industry

Indexed keywords

CLINICAL PRACTICE; CONSENSUS DEVELOPMENT; DRUG INDUSTRY; EVIDENCE BASED MEDICINE; HUMAN; IATROGENIC DISEASE; MEDICAL EDUCATION; MEDICAL RESEARCH; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; PROFESSIONALISM; REVIEW;

BIOMEDICAL RESEARCH; CLINICAL COMPETENCE; CONFLICT OF INTEREST; EVIDENCE-BASED MEDICINE; HUMANS; MEDICAL ERRORS; PHYSICIANS; PUBLICATIONS; QUALITY OF HEALTH CARE; TRUST;

EID: 32344431679     PISSN: 13561294     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2005.00599.x     Document Type: Review

References (57)

1. Als-Nielsen B., Chen W., Gluud C. & Kjaergard L.L. (2003) Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? Journal of the American Medical Association 290, 921-928.
2. Altman D.G. (2002) Poor-quality medical research: what can journals do? Journal of the American Medical Association 287, 2765-2767.
3. American College of Obstetrics and Gynecology Practice Bulletin (2001) Use of botanicals for management of menopausal symptoms. Clinical Management Guidelines for Obstetricians - Gynecologists 28, 2.
4. Angell M. (2000) Is academic medicine for sale? New England Journal of Medicine 342, 1516-1518.
5. Angell M. (2004) The Truth About the Drug Companies: How They Deceive Us and What To Do About It. Random House, New York.
6. Barbaresi W.J. (2003) Use of psychotropic medications in young, preschool children: primum non nocere. Archives of Pediatrics and Adolescent Medicine 157, 121-123.
7. Chen C.L., Weiss N.S., Newcomb P., Barlow W. & White E. (2002) Hormone replacement therapy in relation to breast cancer. Journal of the American Medical Association 287, 734-741.
8. Classen D.C., Pestotnik S.L., Evans R.S., Lloyd J.F. & Burke J.P. (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. Journal of the American Medical Association 277, 301-306.
9. CMAJ Editorial (2003) Obituary: the Canadian task force on preventive health care. Canadian Medical Association Journal 169, 1137.
10. Feuer C. (2004) Can PEPFAR save the most vulnerable? American Foundation for AIDS Research 5, 1-3.
11. Fitzgerald G.A. (2004) Coxibs and cardiovascular disease. New England Journal of Medicine 351, 1709-1711.
12. Gallo M., Smith M., Boon H. & Koren G. (2001) The use of herbal medicine in pregnancy and lactation. In Maternal and Fetal Toxicology, 3rd edn (ed Koren G.), pp. 569-602. Marcel Dekker, New York, NY.
13. Green C.F., Mottram D.R., Rowe P.H. & Pirmohamed M. (2000) Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. Journal of Clinical Pharmacy and Therapeutics 25, 355-361.
14. Healy D. (2002) Conflicts of interest in Toronto: anatomy of a controversy at the interface of academia and industry. Perspectives in Biology and Medicine 45, 250-263.
15. Herrington D.M. & Howard T.D. (2003) From presumed benefit to potential harm - hormone therapy and heart disease. New England Journal of Medicine 349, 519-521.
16. Hogle J., Green B.C., Nantulya V., Stoneburner R., Stover J. (2002) What happened in Uganda? Declining H.I.V., prevalence, behavior change, and the national response. US Agency for International Development: Office of HIV/AIDS, Bureau of Global Health, Washington DC, 2002. http://www.usaid.gov/our_work/ global_health/aids/Countries/africa/uganda_report.pdf
17. Horton R. (2004) MMR: Science and Fiction. Granta Books, London.
18. Jolly E., Hauck B., Mailloux J., Robichaud A., Rowe T., Sabbah R. & Wolfman W. (2004) Hormone therapy for post-menopausal women in the new millenium. Expert Discussion Forum: Linking Evidence-Based Medicine to Clinical Practice 3, 1-8.
19. Juntti-Patinen L. & Neuvonen P.J. (2002) Drug-related deaths in a University central hospital. European Journal of Clinical Pharmacology 58, 479-482.
20. Kaiza D. (2004) Condoms: why Museveni is no hero in anti-AIDS war. The East African (Periodical, July 21).
21. Kondro W. (2004) UK bans, health Canada warns about antidepressants. Canadian Medical Association Journal 171, 23.
22. Kondro W. & Sibbald B. (2004) Drug company experts advised staff to withhold data about SSRI use in children. Canadian Medical Association Journal 170, 783.
23. Lazarou J., Pomeranz B.H. & Corey P.N. (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. Journal of the American Medical Association 279, 1200-1205.
24. Leape L.L. (1994) Error in medicine. Journal of the American Medical Association 272, 1851-1857.
25. Leiter L., MacFarlane P., Fitchett D., Langer A. & Verma S. [pictured contributors] (2004) Evidence-based medicine: turning clinical research into medical practice. Medical Post 40, 43 (Insert).
26. Lenzer J. (2004a) Pfizer pleads guilty, but drug sales continue to soar. British Medical Journal 328, 1217.
27. Lenzer J. (2004b) Pfizer criticised over delay in admitting drug's problems. British Medical Journal 329, 935.
28. Lexchin J., Bero L.A., Djulbegovic B. & Clark O. (2003) Pharmaceutical industry sponsorship and research outcome and quality: systematic review. British Medical Journal 326, 1167-1170.
29. McGavock H. (2004) Prescription-related illness - a scandalous pandemic. Journal of Evaluation in Clinical Practice 10, 491-497.
30. Marshall B., ed. (2002) Helicobacter Pioneers: Firsthand Accounts from the Scientists Who Discovered Helicobacters. Blackwell, Victoria, Australia.
31. Miles A., Grey J.E., Polychronis A., Price N. & Melchiorri C. (2004) Developments in the evidence-based health care debate - 2004. Journal of Evaluation in Clinical Practice 10, 129-142.
32. Misch D.A. (2002) Evaluating physicians' professionalism and humanism: the case for humanism 'connoisseurs'. Academic Medicine 77, 489-495.
33. Monif G.R.G. (1982) Puerperal sepsis. Infectious Disease Letters Obstetrics and Gynecology 4, 67-72.
34. Moore T.J., Weiss S.R., Kaplan S. & Blaisdell C.J. (2002) Reported adverse drug events in infants and children under 2 years of age. Pediatrics 110, e53.
35. Moynihan R. (2003) Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement. British Medical Journal 326, 1193-1196.
36. Museveni Y.K. (2004) Presentation on HIV/AIDS. XV International AIDS Conference July 11-16, 2004. Bangkok, Thailand.
37. Nettleton S. (1995) The Sociology of Health and Illness. Polity Press, Cambridge.
38. NIH Consensus Conference (1994) Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Journal of the American Medical Association 272, 65-69.
39. Olivieri N.F. (2003) Patients' health or company profits? The commercialisation of academic research. Science and Engineering Ethics 9, 29-41.
40. Onder G., Pedone C., Landi F., Cesari M., Della Vedova C., Bernabei R. & Gambassi G. (2002) Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). Journal of the American Geriatrics Society 50, 1962-1968.
41. Relman A.S. & Angell M. (2002) America's other drug problem: how the drug industry distorts medicine and politics. New Republic 587, 27-41.
42. Rochon P.A., Bero L.A., Bay A.M., Gold J.L., Dergal J.M., Binns M.A., Streiner D.L. & Gurwitz J.H. (2002) Comparison of review articles published in peer-reviewed and throaway journals. Journal of the American Medical Association 287, 2853-2856.
43. Shumaker S.A., Legault C., Rapp S.R. et al. (2003) Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. Journal of the American Medical Association 289, 2651-2662.
44. Sibbald B. (2004) Legal action against GSK over SSRI data. Canadian Medical Association Journal 171, 23.
45. Spirer H.F. & Spirer L. (1991) Death and numbers: Semmelweis the statistician. PSR Quarterly 1, 43-52.
46. Starfield B. (2000) Is US health really the best in the world? Journal of the American Medical Association 284, 483-485.
47. Steele L. & Fawal H. (2000) 4th Decennial International Conference on nosocomial and healthcare-associated infections: a challenge for change. American Journal of Infection Control 28, 207-210.
48. Straus S.E. & Jones G. (2004) What has evidence based medicine done for us? British Medical Journal 329, 987-988.
49. Thomas E.J. & Brennan T.A. (2000) Incidence and types of preventable adverse events in elderly patients: population based review of medical records. British Medical Journal 320, 741-744.
50. Tomita T. & Zhao Q. (2002) Autopsy findings of heart and lungs in a patient with primary pulmonary hypertension associated with use of fenfluramine and phentermine. Chest 121, 649-652.
51. Topol E.J. (2004) Failing the public health - rofecoxib, Merck, and the FDA. New England Journal of Medicine 351, 1707-1709.
52. Uganda tackles AIDS from the very top down (1999) AIDS Alert 14 (8 Suppl.), 3-4.
53. Vass A. (2002) What's a good doctor, and how can you make one? British Medical Journal 325, 667-668.
54. Wassertheil-Smoller S., Hendrix S.L., Limacher M. et al. (2003) Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. Journal of the American Medical Association 289, 2673-2684.
55. Wassertheil-Smoller S., Psaty B., Greenland P., Oberman A., Kotchen T., Mouton C., Black H., Aragaki A. & Trevisan M. (2004) Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Journal of the American Medical Association 292, 2849-2859.
56. Weingart S.N. & Iezzoni L.I. (2003) Looking for medical injuries where the light is bright. Journal of the American Medical Association 290, 1917-1919.
57. Zhan C. & Miller M.R. (2003) Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. Journal of the American Medical Association 290, 1868-1874.